nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM3—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0759	0.0759	CbGpPWpGaD
Phenoxybenzamine—CALM2—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0735	0.0735	CbGpPWpGaD
Phenoxybenzamine—CALM1—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0735	0.0735	CbGpPWpGaD
Phenoxybenzamine—CALM3—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0499	0.0499	CbGpPWpGaD
Phenoxybenzamine—CALM2—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0482	0.0482	CbGpPWpGaD
Phenoxybenzamine—CALM1—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0482	0.0482	CbGpPWpGaD
Phenoxybenzamine—CALM3—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0481	0.0481	CbGpPWpGaD
Phenoxybenzamine—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0465	0.0465	CbGpPWpGaD
Phenoxybenzamine—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0465	0.0465	CbGpPWpGaD
Phenoxybenzamine—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.0117	0.0117	CbGpPWpGaD
Phenoxybenzamine—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.0113	0.0113	CbGpPWpGaD
Phenoxybenzamine—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.0113	0.0113	CbGpPWpGaD
Phenoxybenzamine—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.0112	0.0112	CbGpPWpGaD
Phenoxybenzamine—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.0112	0.0112	CbGpPWpGaD
Phenoxybenzamine—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.0108	0.0108	CbGpPWpGaD
Phenoxybenzamine—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.0105	0.0105	CbGpPWpGaD
Phenoxybenzamine—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.0105	0.0105	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0103	0.0103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00721	0.00721	CbGpPWpGaD
Phenoxybenzamine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.007	0.007	CbGpPWpGaD
Phenoxybenzamine—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00679	0.00679	CbGpPWpGaD
Phenoxybenzamine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00677	0.00677	CbGpPWpGaD
Phenoxybenzamine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00677	0.00677	CbGpPWpGaD
Phenoxybenzamine—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00657	0.00657	CbGpPWpGaD
Phenoxybenzamine—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00657	0.00657	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00643	0.00643	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00599	0.00599	CbGpPWpGaD
Phenoxybenzamine—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00513	0.00513	CbGpPWpGaD
Phenoxybenzamine—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00497	0.00497	CbGpPWpGaD
Phenoxybenzamine—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00497	0.00497	CbGpPWpGaD
Phenoxybenzamine—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00494	0.00494	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00478	0.00478	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00478	0.00478	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00463	0.00463	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.0045	0.0045	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00448	0.00448	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00448	0.00448	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00409	0.00409	CbGpPWpGaD
Phenoxybenzamine—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00409	0.00409	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00406	0.00406	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00401	0.00401	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00396	0.00396	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00396	0.00396	CbGpPWpGaD
Phenoxybenzamine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00395	0.00395	CbGpPWpGaD
Phenoxybenzamine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00395	0.00395	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00385	0.00385	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00379	0.00379	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00373	0.00373	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00371	0.00371	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00348	0.00348	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00344	0.00344	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00332	0.00332	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00325	0.00325	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.0032	0.0032	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00308	0.00308	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00308	0.00308	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00294	0.00294	CbGpPWpGaD
Phenoxybenzamine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.00289	0.00289	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00284	0.00284	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.00281	0.00281	CbGpPWpGaD
Phenoxybenzamine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.00279	0.00279	CbGpPWpGaD
Phenoxybenzamine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.00279	0.00279	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00273	0.00273	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.00272	0.00272	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.00272	0.00272	CbGpPWpGaD
Phenoxybenzamine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.00266	0.00266	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00266	0.00266	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00265	0.00265	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00264	0.00264	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00262	0.00262	CbGpPWpGaD
Phenoxybenzamine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.00258	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.00258	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00257	0.00257	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00257	0.00257	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.00253	0.00253	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00248	0.00248	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.00245	0.00245	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.00245	0.00245	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00244	0.00244	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00242	0.00242	CbGpPWpGaD
Phenoxybenzamine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00239	0.00239	CbGpPWpGaD
Phenoxybenzamine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00239	0.00239	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00234	0.00234	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00234	0.00234	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00216	0.00216	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—B3GNT2—ankylosing spondylitis	0.00214	0.00214	CbGpPWpGaD
Phenoxybenzamine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.00213	0.00213	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.00206	0.00206	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.00206	0.00206	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00201	0.00201	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—ANTXR2—ankylosing spondylitis	0.00196	0.00196	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—ANTXR2—ankylosing spondylitis	0.0019	0.0019	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—ANTXR2—ankylosing spondylitis	0.0019	0.0019	CbGpPWpGaD
Phenoxybenzamine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	0.00185	0.00185	CbGpPWpGaD
Phenoxybenzamine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	0.00179	0.00179	CbGpPWpGaD
Phenoxybenzamine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	0.00179	0.00179	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1R2—ankylosing spondylitis	0.0017	0.0017	CbGpPWpGaD
Phenoxybenzamine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.0017	0.0017	CbGpPWpGaD
Phenoxybenzamine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.0017	0.0017	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00166	0.00166	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1R2—ankylosing spondylitis	0.00165	0.00165	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1R2—ankylosing spondylitis	0.00165	0.00165	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ERAP1—ankylosing spondylitis	0.00161	0.00161	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	0.00159	0.00159	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ERAP1—ankylosing spondylitis	0.00156	0.00156	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ERAP1—ankylosing spondylitis	0.00156	0.00156	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00154	0.00154	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	0.00154	0.00154	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00153	0.00153	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00151	0.00151	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.0015	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00148	0.00148	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00148	0.00148	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00148	0.00148	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CARD9—ankylosing spondylitis	0.00147	0.00147	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CARD9—ankylosing spondylitis	0.00143	0.00143	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CARD9—ankylosing spondylitis	0.00143	0.00143	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.0014	0.0014	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00138	0.00138	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00136	0.00136	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	0.00135	0.00135	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00134	0.00134	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—B3GNT2—ankylosing spondylitis	0.00131	0.00131	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00127	0.00127	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	0.00125	0.00125	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00125	0.00125	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00122	0.00122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00116	0.00116	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—B3GNT2—ankylosing spondylitis	0.00116	0.00116	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00114	0.00114	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00113	0.00113	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00113	0.00113	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—B3GNT2—ankylosing spondylitis	0.00112	0.00112	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—B3GNT2—ankylosing spondylitis	0.00112	0.00112	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00111	0.00111	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00107	0.00107	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—B3GNT2—ankylosing spondylitis	0.00106	0.00106	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00103	0.00103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	0.00097	0.00097	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000968	0.000968	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000956	0.000956	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000949	0.000949	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000941	0.000941	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	0.00094	0.00094	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	0.000938	0.000938	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	0.000938	0.000938	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-C—ankylosing spondylitis	0.000926	0.000926	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000918	0.000918	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000918	0.000918	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000911	0.000911	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000911	0.000911	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	0.00091	0.00091	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	0.00091	0.00091	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000904	0.000904	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000903	0.000903	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-C—ankylosing spondylitis	0.000896	0.000896	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-C—ankylosing spondylitis	0.000896	0.000896	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00089	0.00089	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00089	0.00089	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000873	0.000873	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000873	0.000873	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000837	0.000837	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	0.000831	0.000831	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000809	0.000809	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000809	0.000809	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1RN—ankylosing spondylitis	0.000805	0.000805	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	0.000804	0.000804	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	0.000804	0.000804	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000803	0.000803	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	0.000797	0.000797	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000793	0.000793	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000791	0.000791	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1RN—ankylosing spondylitis	0.000778	0.000778	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1RN—ankylosing spondylitis	0.000778	0.000778	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	0.000771	0.000771	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	0.000771	0.000771	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00075	0.00075	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000739	0.000739	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000735	0.000735	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD79A—ankylosing spondylitis	0.000706	0.000706	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD79A—ankylosing spondylitis	0.000683	0.000683	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD79A—ankylosing spondylitis	0.000683	0.000683	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00067	0.00067	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000656	0.000656	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000648	0.000648	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000648	0.000648	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP3—ankylosing spondylitis	0.000634	0.000634	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000609	0.000609	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1A—ankylosing spondylitis	0.000579	0.000579	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD40LG—ankylosing spondylitis	0.000576	0.000576	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000572	0.000572	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000565	0.000565	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1A—ankylosing spondylitis	0.00056	0.00056	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1A—ankylosing spondylitis	0.00056	0.00056	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD40LG—ankylosing spondylitis	0.000557	0.000557	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD40LG—ankylosing spondylitis	0.000557	0.000557	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000556	0.000556	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-B—ankylosing spondylitis	0.000548	0.000548	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000538	0.000538	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000538	0.000538	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP3—ankylosing spondylitis	0.000534	0.000534	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-B—ankylosing spondylitis	0.00053	0.00053	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-B—ankylosing spondylitis	0.00053	0.00053	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000526	0.000526	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-A—ankylosing spondylitis	0.000507	0.000507	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-A—ankylosing spondylitis	0.000491	0.000491	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-A—ankylosing spondylitis	0.000491	0.000491	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CRP—ankylosing spondylitis	0.000484	0.000484	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HLA-A—ankylosing spondylitis	0.000469	0.000469	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CRP—ankylosing spondylitis	0.000468	0.000468	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CRP—ankylosing spondylitis	0.000468	0.000468	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000467	0.000467	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—TLR4—ankylosing spondylitis	0.000464	0.000464	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HLA-A—ankylosing spondylitis	0.000453	0.000453	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HLA-A—ankylosing spondylitis	0.000453	0.000453	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	0.000453	0.000453	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—TLR4—ankylosing spondylitis	0.000449	0.000449	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—TLR4—ankylosing spondylitis	0.000449	0.000449	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000434	0.000434	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000396	0.000396	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000383	0.000383	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000383	0.000383	CbGpPWpGaD
